Skip to content

Study · Ex vivo tissue · 1978

2 results

[Use of thymus hormone in the demonstration of acute T-null cell lymphocytic leukemia].

Ozger Topuz U, Astaldi G, Cavdar A

Minerva medica1 Apr 1978

PMID307199 (opens in a new tab)PepBankPUB-00307199
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueActivity measurement

    In peripheral blood cells from ALL patients, human serum thymic factor increased E+ cell numbers in 3 of 24 patients.

    In plain wordsIn lab tests, thymic factor increased E+ cells compared with before incubation in 3 of 24 ALL patients.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    IncreaseE+ cell number
    Study

    humann = 24

    peripheral blood mononuclear cells from ALL patients
    Comparator
    Before thymic factor incubation
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Measurements

    patients with increased E+ cells
    3 patients
    ALL
    patients tested
    24 patients
    ALL

    Source sentences

    Summary
    In 3 out of 24 patients tested, the thymic factor incubation of peripheral-blood mononuclears increased the number of E+cells.
    1 context sentence
    Summary · context
    The Authors studied the effect of the human serum thymic factor on the peripheral-blood leukocytes from ALL patients, by testing the frequency of the E+cells by means of the e rosette assay before and after cell incubation with the above mentioned factor.
  2. 02LabEx vivo tissueActivity measurement

    In peripheral blood cells from ALL patients, the thymic factor-induced shift to E+ cells occurred among null cells.

    In plain wordsIn lab tests, human serum thymic factor shifted null cells from ALL patients to E+ cells compared with before incubation.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    IncreaseNull cell shift to E+ cells
    Study

    humann: not reported in source

    peripheral blood mononuclear cells from ALL patients
    Comparator
    Before thymic factor incubation
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The shift from R to E+cells caused by the human serum thymic factor occurred among null cells (E-, SM-Ig-).
    1 context sentence
    Summary · context
    The Authors studied the effect of the human serum thymic factor on the peripheral-blood leukocytes from ALL patients, by testing the frequency of the E+cells by means of the e rosette assay before and after cell incubation with the above mentioned factor.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.